Mucin synthesis inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050249675A1
SERIAL NO

10870926

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENAERA CORPORATION5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chellquist, Eric Plymouth Meeting, PA 3 22
Hung, Hsiao-Ling Plymouth Meeting, PA 2 9
Levitt, Roy C Plymouth Meeting, PA 20 118
McLane, Michael Plymouth Meeting, PA 26 107

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation